A human 3D airway screening platform to identify agents with antiviral activity.
This platform is based on zPREDICTA’s tissue reconstruction technology that incorporates the tissue-specific extracellular matrix (ECM) and cellular components to replicate the tissue architecture and its biology outside the human body.
Characteristics of zPREDICTA’s r-Lung-SARS-CoV-2 model: